Michael Golembiewski

Michael Golembiewski has a extensive work experience spanning over several companies. Michael is currently Chief Financial Officer at Seelos Therapeutics, Inc. Since September 2021. Prior to that, they served as SVP of Finance at Seelos Therapeutics, Inc. from January 2019 to September 2021. Michael worked as VP of Finance at Agile Therapeutics from November 2017 to June 2018. From April 2015 to November 2017, they held the position of VP Finance, Principal Accounting Officer and Corporate Controller at Pernix Therapeutics. From May 2007 to April 2015, they were the Executive Director, Corporate Controller at NPS Pharmaceuticals. Michael served as Corporate Controller at The Topps Company from February 2006 to May 2007. Michael was the Director, Financial Reporting at ImClone Systems from May 1997 to February 2006. Previously, they worked as an Accounting Supervisor at Calton Homes from 1995 to 1997, and as a Sr. Accountant at Dri-Print Foils from 1993 to 1995.

Michael Golembiewski obtained a Bachelor's degree in Accounting from Rider University from 1989 to 1993.